BG102758A - Method for improving of contrast means - Google Patents

Method for improving of contrast means

Info

Publication number
BG102758A
BG102758A BG102758A BG10275898A BG102758A BG 102758 A BG102758 A BG 102758A BG 102758 A BG102758 A BG 102758A BG 10275898 A BG10275898 A BG 10275898A BG 102758 A BG102758 A BG 102758A
Authority
BG
Bulgaria
Prior art keywords
contrast means
microscopic
relates
improving
contrast
Prior art date
Application number
BG102758A
Other languages
Bulgarian (bg)
English (en)
Inventor
Harald Dugstad
Jo Klaveness
Pal Rongved
Roald Skurtveit
Jorun Braenden
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603466.5A external-priority patent/GB9603466D0/en
Priority claimed from GBGB9611894.8A external-priority patent/GB9611894D0/en
Priority claimed from GBGB9625663.1A external-priority patent/GB9625663D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of BG102758A publication Critical patent/BG102758A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BG102758A 1996-02-19 1998-09-09 Method for improving of contrast means BG102758A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9603466.5A GB9603466D0 (en) 1996-02-19 1996-02-19 Improvements in or relating to contrast agents
GBGB9611894.8A GB9611894D0 (en) 1996-06-07 1996-06-07 Improvements in or relating to contrast agents
GBGB9625663.1A GB9625663D0 (en) 1996-12-11 1996-12-11 Improvements in or relating to contrast agents
PCT/GB1997/000459 WO1997029783A1 (en) 1996-02-19 1997-02-19 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
BG102758A true BG102758A (en) 1999-09-30

Family

ID=27268137

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102758A BG102758A (en) 1996-02-19 1998-09-09 Method for improving of contrast means

Country Status (25)

Country Link
US (4) US6221337B1 (cs)
EP (2) EP1331013A3 (cs)
JP (1) JP4418033B2 (cs)
KR (1) KR100500334B1 (cs)
CN (1) CN1278740C (cs)
AP (1) AP890A (cs)
AT (1) ATE238072T1 (cs)
AU (1) AU726503B2 (cs)
BG (1) BG102758A (cs)
CA (1) CA2246779C (cs)
CZ (1) CZ293986B6 (cs)
DE (1) DE69721235T2 (cs)
EA (1) EA001135B1 (cs)
EE (1) EE04224B1 (cs)
ES (1) ES2197986T3 (cs)
HK (1) HK1014872A1 (cs)
HU (1) HU229090B1 (cs)
IL (1) IL125748A (cs)
NZ (1) NZ331509A (cs)
OA (1) OA10839A (cs)
PL (1) PL328406A1 (cs)
PT (1) PT881915E (cs)
SK (1) SK284200B6 (cs)
TR (1) TR199801613T2 (cs)
WO (1) WO1997029783A1 (cs)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784367B2 (en) * 1996-08-02 2006-03-16 Ge Healthcare As Improvements in or relating to contrast agents
NZ334365A (en) 1996-08-02 1999-10-28 Nycomed Imaging As Use of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material for ultrasound imaging of the liver
CA2268324C (en) * 1997-08-12 2007-06-12 Bracco Research S.A. Administrable compositions and methods for magnetic resonance imaging
GB9717476D0 (en) * 1997-08-18 1997-10-22 Nycomed Imaging As Process
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717542D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9726773D0 (en) 1997-12-18 1998-02-18 Nycomed Imaging As Improvements in or relating to ultrasonagraphy
WO1999055837A2 (en) * 1998-04-28 1999-11-04 Nycomed Imaging As Improvements in or relating to separation processes
GB9813568D0 (en) 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6514209B1 (en) 1999-06-07 2003-02-04 Drexel University Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals
US20030103960A1 (en) * 1999-12-22 2003-06-05 Pierre Philippart Sealant and bone generating product
EP2286843A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
KR100373712B1 (ko) * 2000-12-23 2003-02-25 사회복지법인삼성생명공익재단(삼성서울병원) 초음파 조영제 및 그의 제조방법
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
WO2002080774A2 (en) 2001-04-06 2002-10-17 Bracco Research S.A. Method for improved measurement of local physical parameters in afluid-filled cavity
EP1469886B8 (en) * 2002-02-01 2008-01-09 Shimoda Biotech (PTY) LTD Lyophilized pharmaceutical composition of propofol
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
KR20050072496A (ko) 2002-11-29 2005-07-11 아머샴 헬스 에이에스 초음파 촬영 방법
EP1590006B1 (en) * 2003-02-04 2010-09-08 Bracco Suisse SA Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
DK2949658T3 (en) 2003-03-03 2018-10-01 Dyax Corp Peptides that specifically bind HGF receptor (cMet) and uses thereof
US20060222694A1 (en) * 2003-06-27 2006-10-05 Oh Choon K Stabilized topotecan liposomal composition and methods
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
NO20035401D0 (no) * 2003-12-04 2003-12-04 Amersham Health As Metode
AU2004308757B2 (en) * 2003-12-22 2010-06-17 Bracco Suisse S.A. Assembly of gas-filled microvesicle with active component for contrast imaging
CA2547024C (en) 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
WO2006018433A1 (en) 2004-08-18 2006-02-23 Bracco Research Sa Gas-filled microvesicles composition for contrast imaging
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
WO2006044996A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for automated boundary detection of body structures
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
US10687785B2 (en) 2005-05-12 2020-06-23 The Trustees Of Columbia Univeristy In The City Of New York System and method for electromechanical activation of arrhythmias
WO2007035721A2 (en) * 2005-09-19 2007-03-29 The Trustees Of Columbia University In The City Of New York Ultrasound method to open blood brain barrier
ES2428964T3 (es) 2005-12-09 2013-11-12 Bracco Suisse Sa Conjugados de vectores específicos de una diana-fosfolípidos
EP1797919A1 (en) 2005-12-16 2007-06-20 Bracco Research S.A. Liquid transfer device for medical dispensing containers
EP1991577A2 (en) 2006-01-31 2008-11-19 Parkinson, John F. Modulation of mdl-1 activity for treatment of inflammatory disease
WO2008016992A1 (en) 2006-08-01 2008-02-07 Scimed Life Systems, Inc. Pulse inversion sequences for nonlinear imaging
WO2008027520A2 (en) * 2006-08-30 2008-03-06 The Trustees Of Columbia University In The City Of New York Systems and methods for composite elastography and wave imaging
US9446156B2 (en) 2006-09-05 2016-09-20 Bracco Suisse S.A. Gas-filled microvesicles with polymer-modified lipids
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
JP2010005512A (ja) * 2008-06-25 2010-01-14 Kao Corp 微細気泡前駆体組成物
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2010014977A1 (en) * 2008-08-01 2010-02-04 The Trustees Of Columbia University In The City Of New York Systems and methods for matching and imaging tissue characteristics
WO2010030819A1 (en) 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Systems and methods for opening a tissue
EP2334239A4 (en) * 2008-09-10 2011-10-19 Univ Columbia ISOLATION OF SIZED RANGE MICROBULLES SELECTED FROM POLYDISPERSED MICROBULLES
WO2011025893A1 (en) 2009-08-28 2011-03-03 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
EP2477550A4 (en) * 2009-09-15 2013-12-04 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR MICROBULLES
EP2480144B1 (en) 2009-09-21 2024-03-06 The Trustees of Columbia University in the City of New York Systems for opening of a tissue barrier
US9700640B2 (en) * 2009-09-21 2017-07-11 Drexel University Stabilized ultrasound contrast agent
US8834846B2 (en) 2010-05-06 2014-09-16 Bruker Biospin Corporation Fluorescent NIRF activatable probes for disease detection
WO2012019172A1 (en) * 2010-08-06 2012-02-09 The Trustees Of Columbia University In The City Of New York Medical imaging contrast devices, methods, and systems
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2012162664A1 (en) 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
BR112014026783B1 (pt) 2012-04-30 2020-12-15 Ge Healthcare As Processo para preparar um recipiente enchido com uma composição
BR112014032254B1 (pt) 2012-06-26 2022-11-01 Ge Healthcare As Processo para a preparação de uma composição, aparelho, e, uso de um aparelho
WO2014059170A1 (en) 2012-10-10 2014-04-17 The Trustees Of Columbia University In The City Of New York Systems and methods for mechanical mapping of cardiac rhythm
JP6313329B2 (ja) 2012-12-21 2018-04-18 ブラッコ・スイス・ソシエテ・アノニムＢｒａｃｃｏ Ｓｕｉｓｓｅ ＳＡ ガス封入マイクロベシクル
WO2014142926A1 (en) 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
CA2902209A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
US9247921B2 (en) 2013-06-07 2016-02-02 The Trustees Of Columbia University In The City Of New York Systems and methods of high frame rate streaming for treatment monitoring
US10322178B2 (en) 2013-08-09 2019-06-18 The Trustees Of Columbia University In The City Of New York Systems and methods for targeted drug delivery
US10028723B2 (en) 2013-09-03 2018-07-24 The Trustees Of Columbia University In The City Of New York Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
GB201405735D0 (en) * 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
DK3233136T3 (da) 2014-12-18 2019-05-20 Bracco Suisse Sa Formulering med målrettede gasfyldte mikrovesikler
EP3308779B1 (en) * 2015-06-10 2019-08-07 Teikyo University Theranostic bubble preparation (tb), and method for using same
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
IN172208B (cs) * 1990-04-02 1993-05-01 Sint Sa
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9511488D0 (en) * 1995-06-07 1995-08-02 Nycomed Imaging As Improvements in or relating to contrast agents
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator

Also Published As

Publication number Publication date
CZ262598A3 (cs) 1999-05-12
US20030202942A1 (en) 2003-10-30
US20010010811A1 (en) 2001-08-02
JP2000511510A (ja) 2000-09-05
EP1331013A3 (en) 2004-03-24
CA2246779A1 (en) 1997-08-21
CA2246779C (en) 2008-04-29
NZ331509A (en) 2000-04-28
EA199800745A1 (ru) 1999-02-25
EP0881915B1 (en) 2003-04-23
WO1997029783A1 (en) 1997-08-21
ATE238072T1 (de) 2003-05-15
JP4418033B2 (ja) 2010-02-17
HUP9900813A2 (hu) 1999-07-28
HUP9900813A3 (en) 1999-11-29
OA10839A (en) 2001-08-13
PT881915E (pt) 2003-09-30
AU726503B2 (en) 2000-11-09
HU229090B1 (en) 2013-07-29
US6221337B1 (en) 2001-04-24
HK1014872A1 (en) 1999-10-08
KR100500334B1 (ko) 2005-09-09
DE69721235D1 (de) 2003-05-28
CZ293986B6 (cs) 2004-09-15
SK284200B6 (sk) 2004-10-05
DE69721235T2 (de) 2004-02-05
KR19990082669A (ko) 1999-11-25
EE9800249A (et) 1999-02-15
IL125748A (en) 2002-05-23
CN1213972A (zh) 1999-04-14
ES2197986T3 (es) 2004-01-16
EE04224B1 (et) 2004-02-16
US20050201942A1 (en) 2005-09-15
AU1884797A (en) 1997-09-02
EP0881915A1 (en) 1998-12-09
AP9801319A0 (en) 1998-09-30
SK112698A3 (en) 1999-04-13
TR199801613T2 (xx) 1998-11-23
PL328406A1 (en) 1999-01-18
AP890A (en) 2000-11-13
CN1278740C (zh) 2006-10-11
EA001135B1 (ru) 2000-10-30
IL125748A0 (en) 1999-04-11
EP1331013A2 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
BG102758A (en) Method for improving of contrast means
CA2025298A1 (fr) Nouveau procede de preparation de microparticules lipidiques
GR3030206T3 (en) Cationic lipids.
PT941066E (pt) Complexos de lipido cationico - acido nucleico
EP1308553A3 (en) Functional fiber products and process for producing same
WO2003086280A3 (en) Immunostimulatory g,u-containing oligoribonucleotides
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
ZA200203102B (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same.
ATE301709T1 (de) Lipidabkömmlinge von pentaerythritol
HUT43080A (en) Compositions containing phospholipide and process for producing them
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
CA2030951A1 (en) Process for producing immunostimulant agents
HK1044343A1 (en) Process for producing deoiled phosphatides.
CA2269077A1 (en) Keratinocyte growth factor-2 products
CA2205790A1 (en) Process for preparing amino-silane compounds, and novel amino-silane compounds
EP0096932A3 (en) Process for making a lyophilized product for use in skeletal imaging
DE69804302D1 (de) Kationische mittel zur transfektion von nukleinsäuren
FR2620333B1 (fr) Liposomes, leur procede de preparation et application desdits liposomes comme vecteur de produits
AU2030595A (en) Incorporation of a water-soluble active principle in a lipid
PT94480A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de isoxazolin-3-ona uteis como antidepressivos
HUT76859A (en) 4-halo-2-fluoro-5-alkoxybenzoyl derivatives, process for preparing such compounds and intermediates thereof
SU1642725A1 (ru) Способ получения ламинарина
IT9021656A0 (it) Sistema di applicazione, per distribuzione, di prodotti ad elevata viscosita'
RU96115431A (ru) Способ рафинации растительных масел
ZA9811804B (en) 11ß-halogen-7Ó-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11ß-halogen-7Ó-substituted estratrienes as well as their use for the production of pharmaceutical agents.